In particular, IL-6 contributes to maintaining pituitary senescence during tumorigenesis by its autocrine action, providing an IL-6-mediated benign tumour senescence model (67, 113, 138, 144, 148, 149). This evidence concerns the gene IL6 and benign neoplasm.